Oliver Sol

Chief Tech/Sci/R&D Officer at AC IMMUNE SA

58 year

Health Technology

Consumer Services

Oliver Sol active positions

Companies	Position	Start	End
AC IMMUNE SA	Chief Tech/Sci/R&D Officer	-	-
AC IMMUNE SA	Corporate Officer/Principal	-	-

Companies	Position	Start	End
EUROBIO SCIENTIFIC	Chief Tech/Sci/R&D Officer	-	-
EUROBIO SCIENTIFIC	General Counsel	-	-
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Chief Tech/Sci/R&D Officer	-	-

International

France	4
Switzerland	2

Operational

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	1
General Counsel	1

Sectoral

Health Technology	4
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	2
AC IMMUNE SA	Health Technology
EUROBIO SCIENTIFIC	Health Technology

Private companies	2
Exonhit Exonhit Pharmaceuticals: MajorHealth Technology Exonhit is developing and manufacturing novel pharmaceuticals from its expertise in the field of alternative RNA splicing, the process by which a single gene can lead to several proteins. The firm's proprietary gene profiling technology DATAS is utilized to identify genes whose splice variants produce abnormal proteins which may trigger or contribute to the development of disease. The company was founded in 1997 and is headquartered in Paris, France.	Health Technology
Université de Paris XI Paris Sud	Consumer Services

Private companies

Health Technology

Université de Paris XI Paris Sud

Consumer Services